GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » EBIT

SANUWAVE Health (SANUWAVE Health) EBIT : $-10.18 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is SANUWAVE Health EBIT?

SANUWAVE Health's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $21.36 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.18 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SANUWAVE Health's annualized ROC % for the quarter that ended in Dec. 2023 was 5.70%. SANUWAVE Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 8,471.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. SANUWAVE Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -19.56%.


SANUWAVE Health EBIT Historical Data

The historical data trend for SANUWAVE Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health EBIT Chart

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.59 -28.40 -20.14 3.84 -10.18

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.54 -8.80 -2.88 -19.86 21.36

Competitive Comparison of SANUWAVE Health's EBIT

For the Medical Devices subindustry, SANUWAVE Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's EV-to-EBIT falls into.



SANUWAVE Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health  (OTCPK:SNWV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SANUWAVE Health's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=4.156 * ( 1 - 0.02% )/( (83.967 + 61.868)/ 2 )
=4.1551688/72.9175
=5.70 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

SANUWAVE Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=85.432/( ( (1.079 + max(-41.772, 0)) + (0.938 + max(-26.806, 0)) )/ 2 )
=85.432/( ( 1.079 + 0.938 )/ 2 )
=85.432/1.0085
=8,471.19 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.231 + 1.713 + 1.355) - (14.415 + 0.068 + 33.588)
=-41.772

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.314 + 2.951 + 1.722) - (15.519 + 0.092 + 19.182)
=-26.806

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

SANUWAVE Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-10.18/52.038
=-19.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health EBIT Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105